Johnson & Johnson (NYSE:JNJ) Holdings Maintained by Fidelity National Financial Inc.

Fidelity National Financial Inc. continued to hold its stake in Johnson & Johnson (NYSE:JNJ) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 58,480 shares of the company’s stock at the close of the second quarter. Johnson & Johnson comprises about 1.8% of Fidelity National Financial Inc.’s portfolio, making the stock its 18th biggest position. Fidelity National Financial Inc.’s holdings in Johnson & Johnson were worth $7,736,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in JNJ. Osborn Williams & Donohoe LLC raised its position in shares of Johnson & Johnson by 0.3% in the 2nd quarter. Osborn Williams & Donohoe LLC now owns 94,031 shares of the company’s stock worth $12,439,000 after acquiring an additional 326 shares in the last quarter. Terra Nova Asset Management LLC grew its stake in shares of Johnson & Johnson by 7.2% in the 2nd quarter. Terra Nova Asset Management LLC now owns 2,970 shares of the company’s stock valued at $393,000 after buying an additional 200 shares during the period. Capital Insight Partners LLC grew its stake in shares of Johnson & Johnson by 0.8% in the 2nd quarter. Capital Insight Partners LLC now owns 30,795 shares of the company’s stock valued at $4,074,000 after buying an additional 250 shares during the period. Dubuque Bank & Trust Co. grew its stake in shares of Johnson & Johnson by 36.7% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 61,400 shares of the company’s stock valued at $8,122,000 after buying an additional 16,475 shares during the period. Finally, Patriot Wealth Management Inc. grew its stake in shares of Johnson & Johnson by 3.5% in the 2nd quarter. Patriot Wealth Management Inc. now owns 98,561 shares of the company’s stock valued at $13,039,000 after buying an additional 3,376 shares during the period. 66.00% of the stock is owned by institutional investors and hedge funds.

Shares of Johnson & Johnson (NYSE JNJ) traded up 0.354% during trading on Friday, hitting $134.655. 7,070,511 shares of the stock traded hands. The firm’s 50-day moving average price is $132.51 and its 200-day moving average price is $129.09. The stock has a market cap of $361.41 billion, a PE ratio of 22.784 and a beta of 0.79. Johnson & Johnson has a 12 month low of $109.32 and a 12 month high of $137.08.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, July 18th. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. Johnson & Johnson had a net margin of 22.52% and a return on equity of 26.76%. The company had revenue of $18.84 billion for the quarter, compared to analysts’ expectations of $18.94 billion. During the same quarter last year, the company earned $1.74 earnings per share. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. Analysts anticipate that Johnson & Johnson will post $7.18 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th were issued a dividend of $0.84 per share. The ex-dividend date of this dividend was Friday, August 25th. This represents a $3.36 dividend on an annualized basis and a yield of 2.50%. Johnson & Johnson’s payout ratio is currently 56.76%.

A number of research firms have issued reports on JNJ. Vetr upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $132.33 target price on the stock in a research note on Thursday, May 18th. J P Morgan Chase & Co lifted their price target on shares of Johnson & Johnson from $140.00 to $148.00 and gave the stock an “overweight” rating in a report on Wednesday, August 16th. BidaskClub raised shares of Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 17th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $128.00 price target (up previously from $124.00) on shares of Johnson & Johnson in a report on Thursday, May 18th. Finally, Wells Fargo & Company reaffirmed a “market perform” rating and issued a $135.00 price target (up previously from $132.00) on shares of Johnson & Johnson in a report on Thursday, July 6th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $134.60.

In other news, VP Dominic J. Caruso sold 82,591 shares of Johnson & Johnson stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $136.72, for a total value of $11,291,841.52. Following the transaction, the vice president now directly owns 226,693 shares of the company’s stock, valued at approximately $30,993,466.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Paulus Stoffels sold 102,692 shares of Johnson & Johnson stock in a transaction on Monday, July 24th. The shares were sold at an average price of $133.14, for a total transaction of $13,672,412.88. Following the completion of the transaction, the vice president now directly owns 230,342 shares in the company, valued at $30,667,733.88. The disclosure for this sale can be found here. 0.19% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: “Johnson & Johnson (NYSE:JNJ) Holdings Maintained by Fidelity National Financial Inc.” was first posted by BBNS and is the property of of BBNS. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://baseballnewssource.com/markets/fidelity-national-financial-inc-has-7736000-stake-in-johnson-johnson-jnj/1605269.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with our FREE daily email newsletter.

 


Latest News

Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster


Leave a Reply

 
© 2006-2017 BBNS.